These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 17918079)

  • 21. Antimicrobial resistance in Europe and its potential impact on empirical therapy.
    Rossolini GM; Mantengoli E
    Clin Microbiol Infect; 2008 Dec; 14 Suppl 6():2-8. PubMed ID: 19040461
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Parenteral polymyxin B use in patients with multidrug-resistant gram-negative bacteremia and urinary tract infections: a retrospective case series.
    Pastewski AA; Caruso P; Parris AR; Dizon R; Kopec R; Sharma S; Mayer S; Ghitan M; Chapnick EK
    Ann Pharmacother; 2008 Sep; 42(9):1177-87. PubMed ID: 18664609
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characterization and anti-microbial susceptibility of gram-negative bacteria isolated from bloodstream infections of cancer patients on chemotherapy in Pakistan.
    Saghir S; Faiz M; Saleem M; Younus A; Aziz H
    Indian J Med Microbiol; 2009; 27(4):341-7. PubMed ID: 19736404
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparative analysis of antibiotic resistance characteristics of Gram-negative bacteria isolated from laying hens and eggs in conventional and organic keeping systems in Bavaria, Germany.
    Schwaiger K; Schmied EM; Bauer J
    Zoonoses Public Health; 2008 Sep; 55(7):331-41. PubMed ID: 18667026
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Epidemiology of multi-drug-resistant gram-negative bacteria: data from an university hospital over a 36-month period.
    Vonberg RP; Wolter A; Chaberny IF; Kola A; Ziesing S; Suerbaum S; Gastmeier P
    Int J Hyg Environ Health; 2008 Jul; 211(3-4):251-7. PubMed ID: 17980660
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The far-reaching impact of antimicrobial resistance.
    Rehm SJ; Weber JT
    Clin Infect Dis; 2007 Sep; 45 Suppl 2():S97-8. PubMed ID: 17683021
    [No Abstract]   [Full Text] [Related]  

  • 27. Multidrug-resistant Gram-negative bacterial infections: the emerging threat and potential novel treatment options.
    Vergidis PI; Falagas ME
    Curr Opin Investig Drugs; 2008 Feb; 9(2):176-83. PubMed ID: 18246520
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vitro evaluation of a new cefixime-clavulanic acid combination for gram-negative bacteria.
    Rawat D; Hasan AS; Capoor MR; Sarma S; Nair D; Deb M; Pillai P; Aggarwal P
    Southeast Asian J Trop Med Public Health; 2009 Jan; 40(1):131-9. PubMed ID: 19323045
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Epidemiology, control and treatment of multiresistant gram-negative rods.
    Wiedemann B
    Drugs; 1996; 52 Suppl 2():95-100; discussion 100-2. PubMed ID: 8869845
    [No Abstract]   [Full Text] [Related]  

  • 30. Comparative activity of meropenem in US medical centers (2007): initiating the 2nd decade of MYSTIC program surveillance.
    Jones RN; Kirby JT; Rhomberg PR
    Diagn Microbiol Infect Dis; 2008 Jun; 61(2):203-13. PubMed ID: 18329835
    [TBL] [Abstract][Full Text] [Related]  

  • 31. What is in the pipeline for Gram-negative pathogens?
    Talbot GH
    Expert Rev Anti Infect Ther; 2008 Feb; 6(1):39-49. PubMed ID: 18251663
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Emergence of extensive drug resistance (XDR) among Gram-negative bacilli in South Africa looms nearer.
    Brink A; Feldman C; Richards G; Moolman J; Senekal M
    S Afr Med J; 2008 Aug; 98(8):586, 588, 590 passim. PubMed ID: 18928032
    [No Abstract]   [Full Text] [Related]  

  • 33. Extended spectrum beta-lactamases among gram-negative bacteria from an Egyptian pediatric hospital: a two-year experience.
    Zaki Mel S
    J Infect Dev Ctries; 2007 Dec; 1(3):269-74. PubMed ID: 19734604
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bacterial colonization: can we live with it?
    Kirkland KB
    Clin Infect Dis; 2009 May; 48(10):1382-4. PubMed ID: 19348595
    [No Abstract]   [Full Text] [Related]  

  • 35. The role of gram-negative bacteria in healthcare-associated pneumonia.
    Restrepo MI; Anzueto A
    Semin Respir Crit Care Med; 2009 Feb; 30(1):61-6. PubMed ID: 19199188
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Increasing extended-spectrum beta-lactamase production and quinolone resistance among Gram-negative bacilli causing intra-abdominal infections in the Asia/Pacific region: data from the Smart Study 2002-2006.
    Ko WC; Hsueh PR
    J Infect; 2009 Aug; 59(2):95-103. PubMed ID: 19564044
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Re: Acute bacterial prostatitis in Korea.
    Etienne M; Caron F
    Int J Antimicrob Agents; 2009 Aug; 34(2):185-6. PubMed ID: 19342203
    [No Abstract]   [Full Text] [Related]  

  • 38. Changes in gastrointestinal carriage of multi-resistant Gram-negative bacilli in a predominantly rural population served by a district general hospital.
    Jenkinson L; Smullen J; Weightman NC; Kerr KG
    J Clin Pathol; 2012 Apr; 65(4):376-7. PubMed ID: 21965826
    [No Abstract]   [Full Text] [Related]  

  • 39. Impact of a hospital-wide antimicrobial formulary intervention on the incidence of multidrug-resistant gram-negative bacteria.
    Furtado GH; Perdiz LB; Santana IL; Camargo MM; Parreira FC; Angelieri DB; Medeiros EA
    Am J Infect Control; 2008 Nov; 36(9):661-4. PubMed ID: 18834728
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Current epidemiology of multidrug‐resistant gram‐negative bacilli in the United States.
    Kallen AJ; Srinivasan A
    Infect Control Hosp Epidemiol; 2010 Nov; 31 Suppl 1():S51-4. PubMed ID: 20929371
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.